Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Chiba

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Cancer Research|March 1, 1990
Purine metabolism of human glioblastoma in vivoK Pillwein, P Chiba, A Knoflach, et al.
Journal of Medicinal Chemistry|November 22, 1996
Structure-activity relationship studies on benzofuran analogs of propafenone-type modulators of tumor cell multidrug resistanceG Ecker, P Chiba, M Hitzler, et al.
International Journal of Cancer|August 19, 1993
Cytotoxicity, differentiating activity and metabolism of tiazofurin in human neuroblastoma cellsK Pillwein, K Schuchter, G Ressmańn, et al.
Biochemical Pharmacology|April 21, 2007
Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24)P Heffeter, M A Jakupec, W Körner, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 28, 2004
Intrinsic and acquired forms of resistance against the anticancer ruthenium compound KP1019 [indazolium trans-[tetrachlorobis(1H-indazole)ruthenate (III)] (FFC14A)P Heffeter, M Pongratz, E Steiner, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Cancer Research|March 1, 1990
Purine metabolism of human glioblastoma in vivoK Pillwein, P Chiba, A Knoflach, et al.
Journal of Medicinal Chemistry|November 22, 1996
Structure-activity relationship studies on benzofuran analogs of propafenone-type modulators of tumor cell multidrug resistanceG Ecker, P Chiba, M Hitzler, et al.
International Journal of Cancer|August 19, 1993
Cytotoxicity, differentiating activity and metabolism of tiazofurin in human neuroblastoma cellsK Pillwein, K Schuchter, G Ressmańn, et al.
Biochemical Pharmacology|April 21, 2007
Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24)P Heffeter, M A Jakupec, W Körner, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 28, 2004
Intrinsic and acquired forms of resistance against the anticancer ruthenium compound KP1019 [indazolium trans-[tetrachlorobis(1H-indazole)ruthenate (III)] (FFC14A)P Heffeter, M Pongratz, E Steiner, et al.
Pageof 5